Delivery Order W911SG07D0009-0005

The National Institute of Environmental Health Sciences awarded a $7,530 firm fixed-price BPA call contract to Reprocell U.S.A., Inc. on May 21, 2014, with completion targeted for June 30, 2014. The contract covers genotyping analysis services utilizing Reprocell's catalog items BIO1020 and BIO1030, with work to be performed in Calverton, Maryland. This award was not designated as a set-aside contract and was procured through the company's existing blanket purchase agreement vehicle with the...

The Food and Drug Administration awarded a contract to Charles River Laboratories, Inc. for sperm cryopreservation services valued at $3,077.80. This is a Blanket Purchase Agreement (BPA) call with a firm fixed price structure and no small business set-aside designation. The contract is scheduled for completion on February 27, 2026, and will be performed at Charles River's facility in Wilmington, Massachusetts. Sperm cryopreservation is a critical capability that supports the preservation and...

Charles River Laboratories, Inc. was awarded a firm fixed-price contract valued at $6,080 by the National Institute of Child Health and Human Development (NICHD) on March 15, 2011, with completion scheduled for March 31, 2011. The contract, issued as a Blanket Purchase Agreement (BPA) call with no set-aside designation, procures one breeding pair of Annexin C57BL/6J Annexin A1-deficient mice for delivery to Bethesda, Maryland. This specialized laboratory animal supports the NICHD's research...

<p>The National Human Genome Research Institute awarded a purchase order to Reprocell U.s.a., Inc. for $18,398.20 on January 30, 2020, for DNA extractions. Work is performed at Calverton, Maryland. The order is firm fixed price with an ultimate completion date of February 29, 2020.</p>

The National Institutes of Health's National Institute of Child Health and Human Development awarded a $19,507 purchase order to The Jackson Laboratory of Bar Harbor, Maine. The firm fixed price contract is for a mouse management and breeding program in support of the Institute's research efforts. No major subcontractors or set aside designations were indicated. The Jackson Laboratory will provide services and products related to maintaining and propagating mice through June 30, 2011 to assist...

This contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Genecopoeia, Inc. Genecopoeia is a minority-owned, Asian-Pacific American-owned, for-profit manufacturer of goods registered to receive federal awards since 2006. The $16,500 firm-fixed-price purchase order does not have a set-aside designation. Genecopoeia, a provider of scientific research materials and services, is...

<p>The National Institute of Child Health and Human Development awarded a purchase order to the State of Maryland on June 6, 2018, for manduca sexta embryo microinjection, with a ceiling value of $2,533.00 and an ultimate completion date of June 5, 2019. The work is performed in Cape St Claire, Maryland, under firm fixed-price terms.</p>

This federal contract award, valued at $24,179.30, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to the nonprofit Jackson Laboratory to support the &quot;MOUSE BREEDING PROJECT&quot; for the production and breeding of research mice. This contract did not have a set-aside designation. The Jackson Laboratory is a leading provider of specialized laboratory mice...

Genoway has been awarded a firm fixed price purchase order valued at twenty-eight thousand nine hundred thirty-three dollars by the Department of Health and Human Services Food and Drug Administration to develop a RFWD2 conditional knock-out mouse line. The period of performance is scheduled to conclude on July 12, 2021. No set-aside designation was utilized for this procurement. Genoway is a for-profit biotechnology firm that specializes in developing genetically modified mouse, rat, and cell...

Bio-Rad Laboratories, Inc.'s Life Science Group Division received a $8,890.94 firm fixed-price purchase order from the Office of Naval Research for polymerase chain reaction (PCR) reagents, with a completion deadline of July 15, 2014. The contract was awarded on July 8, 2014, without small business set-aside designation, and performance is scheduled for Bio-Rad's facility in Hercules, California. As a global leader in life science research and clinical diagnostics, Bio-Rad has maintained a...